Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma | BMC Nephrology | Full Text
Human Kappa Free Light Chain Assay | Diazyme Laboratories, Inc.
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Salivary kappa (A) and lambda (B) free light chain (FLC) secretion... | Download Scientific Diagram
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
Cells | Free Full-Text | Kappa Free Light Chains in the Context of Blood Contamination, and Other IgA- and IgM-Related Cerebrospinal Fluid Disease Pattern | HTML
Demonstration of the correlation between serum free light chains and... | Download Scientific Diagram
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients - Kidney International Reports
Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
The Proximal Tubule Toxicity of Immunoglobulin Light Chains - Kidney International Reports
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation
COMPARISON OF FREELITETM AND N LATEX SERUM FREE LIGHT CHAIN ASSAYS IN SUBJECTS WITH END STAGE RENAL DISEASE ON HAEMODIALYSIS
Is accuracy of serum free light chain measurement achievable?
Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees | Blood Cancer Journal
UHL GP NEWS
CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis - Mayo Clinic Proceedings
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal
